WHO ICTRP trial
Comparison of the Botulinum toxin type A with oral Tizanidine in the treatment…
IRCT2012112411563N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2012112411563N1 |
|---|---|
| Public title | Comparison of the Botulinum toxin type A with oral Tizanidine in the treatment of spasticity due to stroke |
| Scientific title | Comparison of the efficacy of intra-muscular Botulinum toxin type A with oral Tizanidine in the treatment of upper limb spasticity and functional improvement due to cerebral stroke. |
| Primary sponsor | Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Spasticity due to cerebral stroke. Sequelae of cerebral infarction;Sequelae of cerebral infarction |
| Interventions | Intervention 1: For Tizanidine group: Tizanidine will be started with 2 mg/day orally and added 2 mg/week until the dose of 16 mg/day in week 16. Intervention 2: In Botulinum group, patients will be injected two doses of Botulinum (not more… |
| Registration date | Dec 6, 2012 |
| Target size | 68 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: